id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0800-0026,FDA,FDA-2011-D-0800,Guidance for Industry on Regulatory Classification of Pharmaceutical Co- Crystals; Availability,Notice,Notice of Availability,2013-04-26T04:00:00Z,2013,4,2013-04-26T04:00:00Z,,2016-08-01T12:21:23Z,2013-09872,0,0,09000064812a9571
FDA-2011-D-0800-0027,FDA,FDA-2011-D-0800,Guidance for Industry on Regulatory Classification of Pharmaceutical Co- Crystals,Other,Guidance,2013-04-26T04:00:00Z,2013,4,2013-04-26T04:00:00Z,,2019-08-20T18:44:08Z,,0,0,09000064812a87f4